172 related articles for article (PubMed ID: 19004527)
1. The apolipoprotein E gene and its age-specific effects on cognitive function.
Liu F; Pardo LM; Schuur M; Sanchez-Juan P; Isaacs A; Sleegers K; de Koning I; Zorkoltseva IV; Axenovich TI; Witteman JC; Janssens AC; van Swieten JC; Aulchenko YS; Oostra BA; van Duijn CM
Neurobiol Aging; 2010 Oct; 31(10):1831-3. PubMed ID: 19004527
[TBL] [Abstract][Full Text] [Related]
2. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E, cardiovascular disease and cognitive function in aging women.
Kang JH; Logroscino G; De Vivo I; Hunter D; Grodstein F
Neurobiol Aging; 2005 Apr; 26(4):475-84. PubMed ID: 15653176
[TBL] [Abstract][Full Text] [Related]
5. Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.
Yasuno F; Tanimukai S; Sasaki M; Hidaka S; Ikejima C; Yamashita F; Kodama C; Mizukami K; Michikawa M; Asada T
Am J Geriatr Psychiatry; 2012 Jul; 20(7):574-83. PubMed ID: 21407046
[TBL] [Abstract][Full Text] [Related]
6. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and cognitive performance: a meta-analysis.
Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
9. Age-related differences in episodic memory: a synergistic contribution of genetic and physiological vascular risk factors.
Bender AR; Raz N
Neuropsychology; 2012 Jul; 26(4):442-50. PubMed ID: 22612575
[TBL] [Abstract][Full Text] [Related]
10. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.
Levy JA; Bergeson J; Putnam K; Rosen V; Cohen R; Lalonde F; Mirza N; Linker G; Sunderland T
J Int Neuropsychol Soc; 2004 May; 10(3):362-70. PubMed ID: 15147594
[TBL] [Abstract][Full Text] [Related]
11. [Apolipoprotein E4 and memory decline in the elderly].
Jonker C; Dik MG; van Kamp GJ; Deeg DJ
Tijdschr Gerontol Geriatr; 2000 Oct; 31(5):198-202. PubMed ID: 11064931
[TBL] [Abstract][Full Text] [Related]
12. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
13. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
[TBL] [Abstract][Full Text] [Related]
14. Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population.
Payton A; van den Boogerd E; Davidson Y; Gibbons L; Ollier W; Rabbitt P; Worthington J; Horan M; Pendleton N
Genes Brain Behav; 2006; 5 Suppl 1():23-31. PubMed ID: 16417614
[TBL] [Abstract][Full Text] [Related]
15. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
16. ApoE4 allele is associated with late-life depression: a population-based study.
Yen YC; Rebok GW; Gallo JJ; Yang MJ; Lung FW; Shih CH
Am J Geriatr Psychiatry; 2007 Oct; 15(10):858-68. PubMed ID: 17911363
[TBL] [Abstract][Full Text] [Related]
17. Does possession of apolipoprotein E ɛ4 benefit cognitive function in healthy young adults?
Bunce D; Anstey KJ; Burns R; Christensen H; Easteal S
Neuropsychologia; 2011 Jun; 49(7):1693-7. PubMed ID: 21396385
[TBL] [Abstract][Full Text] [Related]
18. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
[TBL] [Abstract][Full Text] [Related]
20. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
